Richard Bernstein Advisors LLC Zoetis Inc. Transaction History

Richard Bernstein Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	BUY	$193.69 - $247.03 $3.35 Million - $4.27 Million	17,279 New	17,279 $4.22 Million
Q2 2020 Aug 14, 2020	SELL	$111.92 - $142.53 $753,781 - $959,939	-6,735 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$92.66 - $144.94 $2.58 Million - $4.04 Million	-27,872 Reduced 80.54%	6,735 $792,000
Q3 2019 Nov 14, 2019	SELL	$112.57 - $128.43 $851,141 - $971,059	-7,561 Reduced 17.93%	34,607 $4.31 Million
Q3 2018 Nov 13, 2018	BUY	$83.5 - $93.23 $3.52 Million - $3.93 Million	42,168 New	42,168 $3.86 Million

1,956

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Richard Bernstein Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Richard Bernstein Advisors LLC with notifications on news.